AnaptysBio, Inc.（ANAB）價格預測ANABAnaptysBio, Inc.

Alphio's ANAB stock price prediction model matches the current AnaptysBio, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $46.03 (-1.24%). The 1-week path is $47.05 (+0.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

AnaptysBio is currently not a strong buy due to its current price of $46.61 being below the recent analyst price targets, which range from $60 to $90. The RSI is at 42.212, indicating it is nearing oversold territory, but the recent earnings report showed a significant net income of $183.88 million driven by a tax benefit, suggesting potential for recovery. However, the risk remains high with a forward P/E of 21.0084, indicating that the stock may be overvalued based on future earnings expectations, especially considering the volatility in its earnings and the recent litigation outcomes.

AnaptysBio, Inc. (ANAB) last closed at $46.61, losing -4.31%. These facts feed the 1-day and 1-week ANAB price prediction above.